中島和寿先生の論文が International Journal of Clinical Oncology に掲載されました！おめでとうございます！

論文タイトル：

「Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology」

ジャーナル名：

International Journal of Clinical Oncology（IF 2.5）

DOI：https://doi.org/10.1007/s10147-024-02663-4